- Home
- AHMA vs TCRX Comparison
AHMA vs TCRX Comparison
Compare AHMA & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AHMA | TCRX |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United Arab Emirates | United States |
| Employees | 44 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.6M | 67.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AHMA | TCRX |
|---|---|---|
| Price | $1.72 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 1.5M | 988.5K |
| Earning Date | 05-22-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,325,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.81 |
| P/E Ratio | $180.72 | ★ N/A |
| Revenue Growth | N/A | ★ 266.65 |
| 52 Week Low | $0.76 | $0.83 |
| 52 Week High | $39.50 | $2.57 |
Technical Indicators
Market Signals| Indicator | AHMA | TCRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 44.09 |
| Support Level | $1.64 | $0.91 |
| Resistance Level | $1.82 | $1.21 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 6.91 | 9.55 |
Price Performance
Historical ComparisonAbout AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.